Current investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating promising outcomes in treating weight gain and type second-type disease. Animal evidence suggest a novel action https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/